July 09, 2026
Market insights predict the global biologics CDMO industry will increase from USD 29.34 billion in 2026 to USD 107.17 billion by 2035, achieving a CAGR of 15.48%. In 2024, North America led the biologics CDMO market with 37% share. Asia-Pacific is ex...
August 10, 2026
According to Payal Rabde, who specializes in biopharmaceuticals, biotechnology, and healthcare market research, with 4+ years of experience in market research and industry analysis, this research indicates that the biologics market is set to grow fro...
August 06, 2026
According to Shivani Zoting, who specializes in biopharmaceuticals, healthcare research, and life sciences market analysis, with 5+ years of experience in market research and industry analysis. Her research reveals that the biologics contract manufac...
August 14, 2026
According to Payal Rabde, who specializes in biologics, comprehensive health services, and healthcare market intelligence, with 4+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunitie...
September 07, 2026
According to Payal Rabde, who specializes in testing biological products for contamination, impurities, toxicity, and other safety risks before they reach patients, with 4+ years of experience in market research and industry analysis, extensive resea...
September 03, 2026
According to Payal Rabde, who specializes in providing outsourced research and development services for biologic drugs, including discovery, preclinical studies, clinical trials, bioanalytical testing, and regulatory support, with 4+ years of experie...
April 21, 2026
Projections indicate that, the global Latin America life science market will increase from USD 4.49 billion in 2024 to USD 12.05 billion by 2034, experiencing a CAGR of 10.38% over the next 10 years. The market is expanding rapidly due to rising R&am...
August 03, 2026
Inhalable Biologics Market (By Type: Peptides and Proteins, Vaccines, Monoclonal Antibodies, RNAi-based Therapeutics, Others; By Application: Respiratory diseases, COPD, Asthma, Cystic Fibrosis, COVID-19, Others, Diabetes, Cancer, Others; By Dosage F...
April 21, 2026
Market insights predict, the osteoarthritis therapeutics industry is expected to grow from USD 9.95 billion in 2024 to USD 24.52 billion by 2034, driven by a CAGR of 9.45%. The rising prevalence of osteoarthritis is estimated to drive the growth of t...
February 17, 2026
According to our market projections, the global filtration in biologics market, valued at USD 8.44 billion in 2025, is anticipated to reach USD 29.01 billion by 2035, growing at a CAGR of 13.14% over the next decade. North America was dominant w...
February 17, 2026
According to market projections, the subcutaneous biologics sector is expected to grow from USD 2.1 billion in 2025 to USD 6.01 billion by 2035, reflecting a CAGR of 11.09%. The growing demand for self-administration and the need for targeted therapy...
September 16, 2026
According to Payal Rabde, who specializes in pharmaceuticals, biotechnology, and therapeutic areas, with 4+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities in the spine biologics ...
September 03, 2026
According to market projections, the global retinal biologics market, valued at USD 29.14 billion in 2026, is anticipated to reach USD 57.86 billion by 2035, growing at a CAGR of 7.92% over the next decade. The growing geriatric population drives the...
April 21, 2026
According to market projections, the global cancer biologics market, valued at USD 110.91 billion in 2024, is anticipated to reach USD 232.02 billion by 2034, growing at a CAGR of 7.66% over the next decade. Rising cancer research is anticipated...
April 21, 2026
Market insights predict, the myasthenia gravis industry is expected to grow from USD 1.45 billion in 2024 to USD 2.95 billion by 2034, driven by a CAGR of 7.35%. In 2024, North America led the myasthenia gravis market, with Asia Pacific set for the f...
April 21, 2026
The next-generation therapy market is expanding due to increasing use of cell and gene therapies as well as rising developments in RNA-based therapies. North America led the market due to the robust industries....
April 21, 2026
According to forecasts, the global pharmaceutical drying equipment market will grow from USD 5.84 billion in 2024 to USD 11.64 billion by 2034, with an expected CAGR of 7.14%. Rising demand for biologics and vaccines is estimated to drive the growt...
April 21, 2026
The life science CDMO market is expanding due to it offers inclusive services from drug development through drug manufacturing, and it majorly focuses on affordability and sustainability by reducing the environmental impact, patient-centric approache...
August 26, 2026
Payal Rabde is a Market Research Analyst specializing in the healthcare, pharmaceuticals, biotechnology, and life sciences market. She tracks the growing demand for biologics, increasing approvals of mAbs, and strategic acquisitions. Her research...
+1 9197 992 333
+91 93077 85324
